NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling.

Author(s): Buntsma NC, Gąsecka A, Roos YBWEM, van Leeuwen TG, van der Pol E, Nieuwland R

Publication: Platelets, 2021, Vol. , Page 1-8

PubMed ID: 34697987 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to compare extracellular vesicle (EV) populations between untreated blood and blood after platelet activation, plasma subjected to a single freeze thaw cycle and fresh plasma, plasma from blood that underwent pneumatic tube transport (PTS) and blood that was transported manually, and plasma specimens from blood that experienced a centrifugation delay of up to 24 h at 4°C or room temperature.

Conclusion of Paper

Unstimulated EDTA and citrate blood had comparable concentrations of EVs derived from platelets (CD61+), activated platelet (P-selectin+), erythrocyte (CD235+) and leukocyte (CD45+). Platelet activation with TRAP-6 increased the concentration of platelet- and activated platelet (P-selectin+)-derived EVs in blood, but the magnitude of the change post-platelet activation was greaterin citrate than EDTA blood. PTS transport of citrate blood increased the concentration of platelet-derived EVs in plasma compared to case-matched specimens transported manually; however, PTS transport of EDTA blood increased the concentration of erythrocyte-derived EVs. Citrate and EDTA plasma that underwent a freeze-thaw cycle had lower concentrations of platelet-, erythrocyte-, and leukocyte-derived EVs than fresh plasma. Pre-centrifugation storage of blood had temperature-, anticoagulant- and EV type- dependent effects on EV concentrations.

Studies

  1. Study Purpose

    The purpose of this study was to compare EV populations between untreated blood and blood after platelet activation, plasma subjected to a single freeze-thaw cycle and fresh plasma, plasma from blood that underwent PTS and blood that was transported manually, and plasma from blood that experienced a centrifugation delay of up to 24 h at 4°C or room temperature. Blood from 7 healthy patients was collected in trisodium citrate and K2EDTA tubes after discarding the first 2 mL. To test the effect of platelet activation, specimens were incubated with TRAP-6 for 30 min and compared to untreated controls. To test the effect of pneumatic tube transport, case-matched blood of each tube type from 6 patients was transported by pneumatic tube or transported by hand in a vertical position. To determine the effect of delayed separation of plasma, case-matched tubes from six donors were stored for 0, 6, or 24 h at room temperature or 4°C before plasma separation. To test the effect of freeze-thaw cycling EV concentrations were measured in fresh plasma and again after snap-freezing in liquid nitrogen, storage at -80°C, and thawing at 37°C. Plasma was obtained from all specimens by dual-centrifugation at 2500 g for 15 min, and then snap-frozen in liquid nitrogen and stored at -80°C. Concentrations of EVs were measured directly in blood by flow cytometry.

    Summary of Findings:

    Unstimulated EDTA and citrate blood had comparable concentrations of EVs derived from platelets (CD61+), activated platelet (P-selectin+), erythrocyte (CD235+) and leukocyte (CD45+). Platelet stimulation with TRAP-6 increased the concentration of platelet- and activated platelet (P-selectin+)-derived EVs; the increase was greater in citrate blood than EDTA blood (4.2-fold versus 1.3-fold, P=0.016; and 9.6-fold and 1.9-fold, P=0.031). The concentration of platelet-derived EVs was higher in citrate plasma than EDTA plasma, but no obvious differences were observed for other EV sources. Plasma from citrate blood transported by PTS had 1.9-fold higher concentration of platelet-derived EVs than case-matched plasma that was manually transported as blood (P=0.031) but concentrations of other EV sources(?) were unaffected. In contrast, the concentration of platelet-derived EVs was higher in plasma from EDTA blood transported by PTS than in case-matched specimens transported manually (P=0.031). Citrate and EDTA plasma that underwent a freeze-thaw cycle had lower concentrations of platelet- (26%, P=0.002 and 23%, P=0.002, respectively), erythrocyte- (31%, P=0.010 and 8% P=0.031, respectively), and leukocyte- (36%, P=0.010 and 27%, P=0.004, respectively) derived EVs than case-matched fresh specimens, but concentrations of activated platelet-derived EVs were comparable. A 6 h room temperature delay to centrifugation led to a 1.5-fold increase in platelet-derived EV concentrations in citrate plasma (P=0.031) and a 1.3-fold increase in erythrocyte-derived EV concentrations in EDTA plasma (P=0.031), but concentrations of other EV sources were not affected by a 6 h blood centrifugation delay at room temperature. A progressive increase in platelet-derived EV concentration was found when blood (EDTA or citrate) was stored for 24 h at room temperature before centrifugation. A 6 h 4°C centrifugation delay of citrate blood led to increases in platelet- and leukocyte- derived EV concentrations (10.4-fold, P=0.031 and 1.6-fold P=0.031, respectively), but a 6 h 4°C centrifugation delay of EDTA blood led to an increase in platelet- and erythrocyte-derived EV concentrations (5.4-fold, P=0.094 and 2.3-fold, P=0.031, respectively). A 24 h centrifugation delay at 4°C, resulted in increases in platelet-, erythrocyte-, and leukocyte-derived EVs in both EDTA and citrate plasma.

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Flow cytometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Anticoagulant Potassium EDTA
    Sodium citrate
    Biospecimen Aliquots and Components Centrifugation Centrifugation delays investigated
    Storage Freeze/thaw cycling 0 cycles
    1 cycle
    Storage Storage duration 0 h
    6 h
    24 h
    Storage Storage temperature 4°C
    Room temperature
    Storage Within hospital transportation method Hand-delivered
    Pneumatic tube system
    Biospecimen Aliquots and Components Blood processing method TRAP-6 treated
    Untreated

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...